PHARMACOLOGY OF BINDING OF H-3 SCH-23390 TO D-1 DOPAMINERGIC RECEPTOR-SITES IN RAT STRIATAL TISSUE

被引：68

作者：

FAEDDA, G

KULA, NS

BALDESSARINI, RJ

机构：

[1] MCLEAN HOSP,MAILMAN RES CTR,115 MILL ST,BELMONT,MA 02178

[2] HARVARD UNIV,SCH MED,DEPT PSYCHIAT,BOSTON,MA 02115

[3] HARVARD UNIV,SCH MED,NEUROSCI PROGRAM,BOSTON,MA 02115

来源：

BIOCHEMICAL PHARMACOLOGY | 1989年 / 38卷 / 03期

关键词：

D O I：

10.1016/0006-2952(89)90387-0

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：473 / 480

页数：8

共 44 条

[1] EVIDENCE FOR DIFFERENT STATES OF THE DOPAMINE D1 RECEPTOR - CLOZAPINE AND FLUPERLAPINE MAY PREFERENTIALLY LABEL AN ADENYLATE CYCLASE-COUPLED STATE OF THE D1-RECEPTOR
ANDERSEN, PH
BRAESTRUP, C
[J]. JOURNAL OF NEUROCHEMISTRY, 1986, 47 (06) : 1822 - 1831
[2] A COMPARISON BETWEEN DOPAMINE-STIMULATED ADENYLATE-CYCLASE AND H-3-SCH-23390 BINDING IN RAT STRIATUM
ANDERSEN, PH
GRONVALD, FC
JANSEN, JA
[J]. LIFE SCIENCES, 1985, 37 (21) : 1971 - 1983
[3] BALDESSARINI RJ, 1985, CHEMOTHERAPY PSYCHIA, P14
[4] RELATIVE ACTIVITIES OF SCH 23390 AND ITS ANALOGS IN 3 TESTS FOR D1/DA1 DOPAMINE RECEPTOR ANTAGONISM
BARNETT, A
AHN, H
BILLARD, W
GOLD, EH
KOHLI, JD
GLOCK, D
GOLDBERG, LI
[J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1986, 128 (03) : 249 - 253
[5] CHARACTERIZATION OF THE BINDING OF H-3-SCH 23390, A SELECTIVE D-1 RECEPTOR ANTAGONIST LIGAND, IN RAT STRIATUM
BILLARD, W
RUPERTO, V
CROSBY, G
IORIO, LC
BARNETT, A
[J]. LIFE SCIENCES, 1984, 35 (18) : 1885 - 1893
[6] DECREASING SENSITIVITY TO NEUROLEPTIC AGENTS IN DEVELOPING RATS - EVIDENCE FOR A PHARMACODYNAMIC FACTOR
CAMPBELL, A
BALDESSARINI, RJ
TEICHER, MH
[J]. PSYCHOPHARMACOLOGY, 1988, 94 (01) : 46 - 51
[7] CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[8] PHARMACOLOGICAL EFFECTS OF A SPECIFIC DOPAMINE D-1 ANTAGONIST SCH-23390 IN COMPARISON WITH NEUROLEPTICS
CHRISTENSEN, AV
ARNT, J
HYTTEL, J
LARSEN, JJ
SVENDSEN, O
[J]. LIFE SCIENCES, 1984, 34 (16) : 1529 - 1540
[9] CHRISTENSEN I, 1986, ARZNEIMITTEL-FORSCH, V36-1, P855
[10] CHRISTENSSON EG, 1985, ACTA PHYSIOL SCAND, V124, P281

← 1 2 3 4 5 →